The US HHS has added Duchenne muscular dystrophy and metachromatic leukodystrophy to newborn screening, citing benefits of early detection and access to FDA-approved treatments.

A new study suggests that the prolonged fatigue after mild exercise that occurs in people with many forms of muscular dystrophy is distinct from the inherent muscle weakness caused by the disease. The ...

Please provide your email address to receive an email when new articles are posted on . Viltolarsen preserved muscle function over 2 years and delayed progression of Duchenne muscular dystrophy over 4 ...

The Muscular Dystrophy Clinic is sponsored by the Muscular Dystrophy Association and provides a multidisciplinary clinic serving the needs of adults and children with over 40 types of neuromuscular ...

The inclusion criteria were clinical diagnosis of muscular dystrophy characterized by muscle weakness or hypotonia with early-onset, delayed developmental milestones and mental retardation. Clinical ...

Muscular dystrophy is a type of disease that causes the muscles in your body to lose strength and mass. As your muscles become weaker over time, it may be hard for you to do normal activities.

Muscular dystrophy refers to a group of more than 30 conditions, all of which cause progressive muscle weakness and loss. Some muscular dystrophies progress slowly, and people with those conditions ...

Viltepso (viltolarsen) is a brand-name intravenous infusion that’s prescribed for Duchenne muscular dystrophy in certain people. As with other drugs, Viltepso can cause side effects, such as injection ...

Genetic testing is available for adults as well as in vitro embryos, fetuses, newborns, and older children. Adults Adults planning to have children are advised to get genetic testing for muscular ...

Muscular dystrophies represent a group of inherited primary diseases of muscle, characterized by muscle fiber degeneration and muscle weakness. Classification of these conditions has traditionally ...